The partners will use Cellino's autonomous biomanufacturing tech to produce high-quality autologous iPSCs for Karis' cardiovascular therapy.

Osteochondral autologous transplantation may be an effective treatment option for adolescent athletes with capitellar osteochondritis dissecans, according to results presented here.“This study has ...

Roche has secured approval from the European Commission (EC) for Columvi (glofitamab) plus gemcitabine and oxaliplatin (GemOx ...

BASEL, Switzerland I April 14, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Columvi® (glofitamab) in ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...